Alle verbonden artikelen

Characteristics and Outcomes of Patients in the ICU With Respiratory Syncytial Virus Compared With Those With Influenza Infection: A Multicenter Matched Cohort Study.

Auteurs : Coussement J, Zuber B, Garrigues E, Gros A, Vandueren C, Epaillard N, Voiriot G, Tandjaoui-Lambiotte Y, Lascarrou JB, Boissier F, Lemiale V, Contou D, Hraiech S, Meert AP, Sauneuf B, Munting A, Ricome S, Messika J, Muller G, Njimi H, Grimaldi D
Jaar : 2022
Journal : Chest
Volume : 161
Pagina's : 1475-1484

Bufalin for an innovative therapeutic approach against cancer.

Auteurs : Soumoy L, Ghanem GE, Saussez S, Journe F
Jaar : 2022
Journal : Pharmacol Res
Volume : 184
Pagina's : 106442

Comments on The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis"."

Auteurs : Liberale G, Moreau M, Repullo D
Jaar : 2022
Journal : Ann Surg Oncol
Volume : 29
Pagina's : 7933-7934

Asymmetric labium majus enlargement in an adult: A case report.

Auteurs : Prokurotaite E, Sirtaine N, Buxant F
Jaar : 2022
Journal : Case Rep Womens Health
Volume : 33
Pagina's : e00369

Endoscopic submucosal dissection of a solitary gastric plasmacytoma: third space oddity"."

Auteurs : Rasschaert G, Gkolfakis P, Eisendrath P, Verset L, Devière J, Lemmers A
Jaar : 2022
Journal : Endoscopy
Volume : 54
Pagina's : E732-E734

Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature.

Auteurs : Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguère T
Jaar : 2022
Journal : Cancer
Volume : 128
Pagina's : 14-19

Incidental finding of solitary fibrous tumor of male breast: case report and review of literature.

Auteurs : El-Helou E, Zaiter M, Hoang H, Lelie B, Larsimont D, Awada A, Grosu F, Veys I, Pop CF
Jaar : 2022
Journal : Rom J Morphol Embryol
Volume : 63
Pagina's : 653-657

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis.

Auteurs : Nader-Marta G, Martins-Branco D, Agostinetto E, Bruzzone M, Ceppi M, Danielli L, Lambertini M, Kotecki N, Awada A, de Azambuja E
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100501

Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.

Auteurs : Lopes Cardozo JMN, Drukker CA, Rutgers EJT, Schmidt MK, Glas AM, Witteveen A, Cardoso F, Piccart M, Esserman LJ, Poncet C, van t Veer LJ
Jaar : 2022
Journal : J Clin Oncol
Volume : 40
Pagina's : 1335-1345

Right ventricular longitudinal fractional shortening: a substitute to right ventricular free wall longitudinal strain?

Auteurs : Unger P, Paesmans M, Vachiery JL, Rietz M, Amzulescu M, David-Cojocariu A
Jaar : 2022
Journal : Heart Vessels
Volume : 37
Pagina's : 426-433

A randomized controlled trial assessing behavioral, cognitive, emotional and physiological changes resulting from a communication skills training in physicians caring for cancer patients.

Auteurs : Libert Y, Peternelj L, Bragard I, Marchal S, Reynaert C, Slachmuylder JL, Razavi D
Jaar : 2022
Journal : Patient Educ Couns
Volume : 105
Pagina's : 2888-2898

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.

Auteurs : Chumsri S, Li Z, Serie DJ, Norton N, Mashadi-Hossein A, Tenner K, Brauer HA, Warren S, Danaher P, Colon-Otero G, Partridge AH, Carey LA, Hilbers F, van Dooren V, Holmes E, Di Cosimo S, Werner O, Huober JB, Dueck AC, Sotiriou C, Saura C, Moreno-Aspitia A, Knutson KL, Perez EA, Thompson EA
Jaar : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pagina's : 68

Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systém

Auteurs : Diamand R, Mjaess G, Ploussard G, Fiard G, Oderda M, Lefebvre Y, Sirtaine N, Roumeguère T, Peltier A, Albisinni S
Jaar : 2022
Journal : Prog Urol
Volume : 32
Pagina's : 6S3-6S18

Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era.

Auteurs : Capdevila J, Awada A, Führer-Sakel D, Leboulleux S, Pauwels P
Jaar : 2022
Journal : Cancer Treat Rev
Volume : 106
Pagina's : 102380

Use of fluorescence imaging during lymphatic surgery: A Delphi survey of experts worldwide.

Auteurs : Dip F, Alexandru N, Amore M, Becker C, Belgrado JP, Bourgeois P, Chang EI, Koshima I, Liberale G, Masia J, Mortimer P, Neligan P, Batista BN, Olszewski W, Salvia SA, Suami H, Vankerckhove S, Yamamoto T, Lo Menzo E, White KP, Rosenthal RJ
Jaar : 2022
Journal : Surgery
Volume : 172
Pagina's : S14-S20

Anthracyclines in the treatment of patients with early breast cancer.

Auteurs : Guarneri V, de Azambuja E
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100461

A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer.

Auteurs : Naghibi M, Skinner C, Burden ST, Bozzetti F, Cuerda C, Joly F, Jeppesen P, Lamprecht G, Mundi M, Szczepanek K, Van Gossum A, Wanten G, Pironi L, Lal S
Jaar : 2022
Journal : Clin Nutr ESPEN
Volume : 47
Pagina's : 246-251

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.

Auteurs : Woff E, Salvatore L, Marmorino F, Genovesi D, Critchi G, Guiot T, Ameye L, Sclafani F, Hendlisz A, Flamen P
Jaar : 2022
Journal : J Nucl Med
Volume : 63
Pagina's : 549-555

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

Auteurs : Thouvenin J, Alhalabi O, Carlo M, Carril-Ajuria L, Hirsch L, Martinez-Chanza N, Négrier S, Campedel L, Martini D, Borchiellini D, Chahoud J, Lodi M, Barthélémy P, Hasanov E, Hahn AW, Gil T, Viswanathan SR, Bakouny Z, Msaouel P, Asim Bilen M, Choueiri TK, Albiges L, Tannir NM, Malouf GG
Jaar : 2022
Journal : Oncologist
Volume : 27
Pagina's : 1041-1047

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.

Auteurs : Geyer CE Jr, Garber JE, Gelber Rd, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ
Jaar : 2022
Journal : Ann Oncol
Volume : 33
Pagina's : 1250-1268